- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 29, 2026 | 88.35M sh |
| Shares Diluted | Q1 2026 · Mar 30, 2025 | 87.54M sh |
| Dividends Paid | Q1 2026 · Mar 29, 2026 | $6.2M |
| Dividends Paid restated | Q1 2026 · Mar 30, 2025 | $5.4M |
| Capex | Q1 2026 · Mar 29, 2026 | $13.8M |
| Capex restated | Q1 2026 · Mar 30, 2025 | $38.8M |
| Operating Cash Flow | Q1 2026 · Mar 29, 2026 | −$12.2M |
| Operating Cash Flow restated | Q1 2026 · Mar 30, 2025 | −$20.2M |
| Long Term Debt | Q1 2026 · Mar 29, 2026 | $812M |
| Long Term Debt | Q1 2026 · Dec 28, 2025 | $818.2M |
| Short Term Debt | Q1 2026 · Mar 29, 2026 | $30.3M |
| Short Term Debt | Q1 2026 · Dec 28, 2025 | $31.4M |
| Cash And Equivalents | Q1 2026 · Mar 29, 2026 | $73.7M |
| Cash And Equivalents | Q1 2026 · Dec 28, 2025 | $120.4M |
| Stockholders Equity | Q1 2026 · Mar 29, 2026 | $709.5M |
| Stockholders Equity | Q1 2026 · Dec 28, 2025 | $713.7M |
| Current Liabilities | Q1 2026 · Mar 29, 2026 | $315M |
| Current Liabilities | Q1 2026 · Dec 28, 2025 | $323.2M |
| Total Liabilities | Q1 2026 · Mar 29, 2026 | $1.45B |
| Total Liabilities | Q1 2026 · Dec 28, 2025 | $1.45B |
| Current Assets | Q1 2026 · Mar 29, 2026 | $359.9M |
| Current Assets | Q1 2026 · Dec 28, 2025 | $384.4M |
| Total Assets | Q1 2026 · Mar 29, 2026 | $2.79B |
| Total Assets | Q1 2026 · Dec 28, 2025 | $2.79B |
| Eps Diluted | Q1 2026 · Mar 29, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 30, 2025 | $0.09 |
| Eps Basic | Q1 2026 · Mar 29, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 30, 2025 | $0.09 |
| Sga Expense | Q1 2026 · Mar 29, 2026 | $85.4M |
| Sga Expense restated | Q1 2026 · Mar 30, 2025 | $77.4M |
| Net Income | Q1 2026 · Mar 29, 2026 | −$1.7M |
| Net Income restated | Q1 2026 · Mar 30, 2025 | $7.5M |
| Operating Income | Q1 2026 · Mar 29, 2026 | $7.8M |
| Operating Income restated | Q1 2026 · Mar 30, 2025 | $5.7M |
| Gross Profit | Q1 2026 · Mar 29, 2026 | $91.9M |
| Gross Profit restated | Q1 2026 · Mar 30, 2025 | $82.4M |
| Cost Of Revenue | Q1 2026 · Mar 29, 2026 | $269.4M |
| Cost Of Revenue restated | Q1 2026 · Mar 30, 2025 | $269.7M |
| Revenue | Q1 2026 · Mar 29, 2026 | $361.3M |
| Revenue restated | Q1 2026 · Mar 30, 2025 | $352.1M |